JF
TNGX icon

Jump Financial’s Tango Therapeutics TNGX Stock Holding History

Jump Financial’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-21,494
Closed -$171K – 2266
2024
Q1 		$171K Buy
+21,494
New +$230K ﹤0.01% 1723
2023
Q2 		– Sell
-12,518
Closed -$49.4K – 2161
2023
Q1 		$49.4K Sell
12,518
-5,533
-31% -$32.1K ﹤0.01% 1497
2022
Q4 		$131K Buy
18,051
+4,511
+33% +$31.7K 0.01% 1383
2022
Q3 		$49K Buy
+13,540
New +$57.8K ﹤0.01% 1498

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jump Financial's TNGX Position: Q2 2024 in Review

Jump Financial sold out of Tango Therapeutics (TNGX) in Q2 2024, closing a stake of 21,494 shares — an estimated $171K sold.

Jump Financial first reported a position in TNGX in Q3 2022 and held it in 4 quarters. The position peaked at $171K in Q1 2024. 119 funds tracked by Wall St. Rank hold TNGX as of Q2 2024.

  • Jump Financial reported no remaining Tango Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Jump Financial sold 21,494 Tango Therapeutics shares in Q2 2024, an estimated $171K.
  • Jump Financial first reported a position in Tango Therapeutics in Q3 2022 and held it in 4 quarters.
  • Jump Financial's Tango Therapeutics position peaked at $171K in Q1 2024.
  • 119 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2024.

Based on Jump Financial's 13F filing for Q2 2024, filed 14 Aug 2024.